WITH A VISION FOR A BETTER WORLD
IS A WORLD WITH LIFE
AROUND THE GLOBE
Win Medica is a leading Athens-based pharmaceutical company.
We aim to improve patients access to affordable and innovative treatments leveraging our highly skilled scientific workforce, our strong commercial presence in the Greek market and our strategic commercial collaborations across the globe.
An important key to Win Medica success is the strategic agreements that has entered into with multinational pharmaceutical companies.
Choose a logo for more information.
Novartis focuses primarily in emerging healthcare sectors.
It has an expanded product portfolio that consists of innovative pharmaceuticals, vaccines, diagnostics, as well as over-the-counter drugs. Based in Switzerland, the Novartis Group's companies employ 98,000 people and operate in more than 140 countries around the world.
Seqirus is one of the leading companies in the development and distribution of influenza vaccines worldwide.
Its high quality and efficiency products are available in 35 countries worldwide. The plant in the United States (Holly Springs) is the largest vaccine plant in the world, is a joint venture with the US Government to treat the flu pandemic and has the capacity to produce> 150 million doses within 6 months in case of a flu pandemic.
The Polish company Polpharma is ranked among the top 20 manufacturers of drugs in the world, with sales of 1 billion USD per year.
It employs over 7,000 people in Poland and in international markets. It has 7 production plants in Poland, Russia and Kazakhstan and 6 research and development centers. The portfolio of the Polpharma Group includes 300 products and another 50 products, which are under development.
Pharmanutra SpA is a pharmaceutical company based in Italy and was founded in 2003 with the goal of developing pharmaceutical food and medical devices.
It follows strict quality standards, always making the choice of raw materials that uses one of its top priorities, so that they are selected uniquely and exclusively for the national market.
Welding GmbH & CO. KG founded in 1955 a German privately owned company.
With headquarters in Hamburg, sales offices in Frankfurt and a subsidiary in Lyon, France, the company currently employs more than 120 people. Areas of activity: Commercial activity of active raw materials and excipients and natural substances for human medicines. Development, licensing and sale of generic medicines
Offering a wide range of services covering the areas of quality management and regulatory affairs.
The French company Servier founded in 1954 and today is the first French independent pharmaceutical group.
Servier is present in 149 countries, with more than 22,000 employees, of which 3,000 in Research and has been active in Greece since 1977.
Viatris Hellas has emerged from the merge of Mylan and Upjohn, a company of the Pfizer group, with the goal of better access to treatments.
Viatris offers a diversified portfolio of medicines, including original, generic and bioequivalent products as well as OTC & Pharmacy products.
Accord Healthcare is a Multinational Pharmaceutical company based in the field of Generics and Biotechnology products.
It is active in the development, production and distribution of pharmaceutical products in over 80 countries around the world, including the USA and Canada. In Europe, Accord Healthcare started its business in 2008, while today it has over 9,300 marketing licenses in European Countries.
MAbxience is a Spanish international high-tech biotechnology company specializing in the research, development, production and marketing of biotechnology products for the treatment and prevention of diseases in various therapeutic fields.
Have access to quality products around the world, as well as the supply of affordable and cost-effective medicines to healthcare systems worldwide.
Chemo is a large Spanish pharmaceutical company with 5,000 employees.
Chemo is mainly active in 3 business sectors: Raw material production Product development Product production
Chemo continues to expand its efforts and invest in Research & Development to develop new and improved therapeutic solutions.
The Icelandic company Medis is a global business partner with a presence in over 140 countries.
Specializes in the development of high quality generic drugs. Medis offers a wide product portfolio to pharmaceutical companies. It provides about 100 medicinal products for human use, mainly in the form of tablet, capsule and injectable products.
Sofar S.p.A, an Italian company that produces high quality pharmaceuticals, nutritional supplements and medical devices.
It has been operating in the pharmaceutical industry for over 45 years and its extensive market knowledge allows Sofar to look to the future, taking advantage of its experience, resulting in a specialized and mature presence, characterized by innovative solutions.
The Adamed Group established in Poland to support the research and development of pharmaceutical products.
It complies with the strictest European standards, so its products are currently available in 60 markets around the world including Europe, Australia, New Zealand, South America, Africa, Asia and the Middle East.
Midas Pharma provides products and services across the entire pharmaceutical value chain
Midas Pharma is a prominent and respected partner for pharmaceutical projects in the fields of custom synthesis, finished product development, supply and manufacture of drug substances and drug products, regulatory affairs, patents and in- and out-licensing. With affiliates in the USA, Scandinavia, France, Poland, Italy, China, Japan, Turkey and India, our global presence gives us insights into the needs of our customers.
In this section, you will find all our news and announcements that may interest you, and the latest from the existing site.